Results 151 to 160 of about 26,897 (178)
Effect of different management strategies on outcomes in subarachnoid neurocysticercosis: a descriptive, multicentre, retrospective cohort study in the USA. [PDF]
Guzmán JJ +27 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Parasitology Research, 2003
Praziquantel is the drug of choice for the treatment of all forms of schistosomiasis. This review summarizes the main features of the drug, with special attention being given to those aspects that may be of interest to the practicing physician. After a brief mention of the history, the chemistry, the major available brands and their costs, doses and ...
Donato, Cioli, Livia, Pica-Mattoccia
+7 more sources
Praziquantel is the drug of choice for the treatment of all forms of schistosomiasis. This review summarizes the main features of the drug, with special attention being given to those aspects that may be of interest to the practicing physician. After a brief mention of the history, the chemistry, the major available brands and their costs, doses and ...
Donato, Cioli, Livia, Pica-Mattoccia
+7 more sources
Expert Opinion on Drug Discovery, 2007
Results from infected patients, not cured by multiple doses of praziquantel (PZQ), have been reported from different geographic locations, suggesting that resistance to the drug may be present. This has been coupled with several in vivo (e.g., studies on mice infected with 'resistant isolates') and in vitro tests (e.g., direct application and ...
Sanaa S, Botros, James L, Bennett
openaire +2 more sources
Results from infected patients, not cured by multiple doses of praziquantel (PZQ), have been reported from different geographic locations, suggesting that resistance to the drug may be present. This has been coupled with several in vivo (e.g., studies on mice infected with 'resistant isolates') and in vitro tests (e.g., direct application and ...
Sanaa S, Botros, James L, Bennett
openaire +2 more sources

